Skip to Main Content
Phase COVID-Pilot

Real-Time Surveillance of E-Cigarette, or Vaping, Product-Use Associated Lung Injury (EVALI)

  • Study HIC#:2000027263
  • Last Updated:07/15/2021

The purpose of our research study is to advance our understanding of risk factors for acute illness among people who use vaping or smoking products. Participation in this study will involve surveys, analysis of e-liquids (if used), and analysis of blood and urine.  Research staff will collect some information about your demographics, personal history, and lab results to understand more about you and identify risk factors for health problems.  Research staff would also like to analyze a sample of any e-liquids recently used. You will receive up to $50 for taking part in this study: $20 for competition of the surveys and an additional $30 if you provide small samples of e-liquids that you recently used.

  • Age18 years and older
  • GenderBoth
  • Start Date02/28/2020
  • End Date02/28/2022

Eligibility Criteria

Eligibility Criteria

Inclusion criteria:

  • Hospital admission (YNHH or SRC).
  • Use of tobacco products/vaping in past 90 days.
  • Respiratory symptoms reported at admission. 

 Exclusion Criteria:

  • Anyone who cannot consent for themselves or is under the age of 18.


For more information about this study, contact:

Or contact the Help us Discover team on: